Product Information

AMLODIPINE-VALSARTAN 5-320 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3525 per EA under NDC 62332020790. Its NADAC has been published 465 times since Sep 27, 2017.

FDA first approved this application on Apr 3, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 5-320 MG

Amlodipine and Valsartan
$0.3525per EA

Strength

5; 320 mg/1; mg/1

NDC

62332020790

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202713

FDA Approved

4/3/2015

TE Code

AB

On Market Since

12/1/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 5-320 MG has been published 465 times since Sep 27, 2017, and over the history we have for it it has declined 40.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3525 per EA
All-time high$0.6544 (Nov 10, 2021)
All-time low$0.3525 (Aug 19, 2026)
52-week high$0.5510
52-week low$0.3525
Median price$0.5520
Average price$0.5458
Largest weekly change+59.9% (Jun 19, 2024)
Weeks tracked465
Tracking sinceSep 27, 2017

Price History

1W

-6.6%

1M

-6.6%

3M

-30.7%

6M

-33.7%

1Y

-36.0%

3Y

-41.7%

5Y

-39.0%

All

-40.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 5-320 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-320 MG, manufactured by Alembic Pharmaceuticals Inc., is $0.3525 per EA (NDC 62332020790), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 5-320 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has declined 40.8%. It has been tracked across 465 weekly CMS publications since Sep 27, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-320 MG?

Since Sep 27, 2017, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has ranged from a low of $0.3525 (Aug 19, 2026) to a high of $0.6544 (Nov 10, 2021), with a median of $0.5520 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-320 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 5-320 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-VALSARTAN 5-320 MG?

AMLODIPINE-VALSARTAN 5-320 MG (NDC 62332020790) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.